{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:06:41Z","timestamp":1790831201634,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1C1C1006749"],"award-info":[{"award-number":["2020R1C1C1006749"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A2C2094436"],"award-info":[{"award-number":["2021R1A2C2094436"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN2022230"],"award-info":[{"award-number":["KSN2022230"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.apsb.2022.07.001","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T01:13:54Z","timestamp":1657156434000},"page":"174-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Vitisin B inhibits influenza A virus replication by multi-targeting neuraminidase and virus-induced oxidative stress"],"prefix":"10.1016","volume":"13","author":[{"given":"Eun-Bin","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan-Suck","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Younghoon","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jeong","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyoung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4450-9813","authenticated-orcid":false,"given":"Chun Whan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Gi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2022.07.001_bib1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IDR.S105473","article-title":"Drug resistance in influenza A virus: the epidemiology and management","volume":"10","author":"Hussain","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.apsb.2022.07.001_bib2","doi-asserted-by":"crossref","first-page":"D49","DOI":"10.1016\/j.vaccine.2008.07.039","article-title":"The biology of influenza viruses","volume":"26","author":"Bouvier","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.apsb.2022.07.001_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1743-422X-6-30","article-title":"Influenza virus antigenic variation, host antibody production and new approach to control epidemics","volume":"6","author":"Chen","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2022.07.001_bib4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.coph.2016.08.003","article-title":"Antiviral therapies on the horizon for influenza","volume":"30","author":"Naesens","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.apsb.2022.07.001_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/med.21289","article-title":"Emerging antiviral strategies to interfere with influenza virus entry","volume":"34","author":"Vanderlinden","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2022.07.001_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/irv.12051","article-title":"Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors","volume":"7","author":"Okomo-Adhiambo","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-019-1258-x","article-title":"Influenza A virus hemagglutinin mutations associated with use of neuraminidase inhibitors correlate with decreased inhibition by anti-influenza antibodies","volume":"16","author":"Ilyushina","year":"2019","journal-title":"Virol J"},{"key":"10.1016\/j.apsb.2022.07.001_bib8","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/v9120376","article-title":"Host cell restriction factors that limit influenza A infection","volume":"9","author":"Villal\u00f3n-Letelier","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.virusres.2004.02.034","article-title":"Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors","volume":"103","author":"Gubareva","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.apsb.2022.07.001_bib10","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2165\/11531450-000000000-00000","article-title":"Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses","volume":"69","author":"Hurt","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2022.07.001_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001015","article-title":"Oseltamivir-resistant pandemic A\/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets","volume":"6","author":"Hamelin","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2022.07.001_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3390\/v13040624","article-title":"Antivirals targeting the surface glycoproteins of influenza virus: mechanisms of action and resistance","volume":"13","author":"Bai","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/JVI.02485-14","article-title":"Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors","volume":"89","author":"Baek","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2022.07.001_bib14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"Samson","year":"2013","journal-title":"Antivir Res"},{"key":"10.1016\/j.apsb.2022.07.001_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.apsb.2022.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01580-17","article-title":"Screening for neuraminidase inhibitor resistance markers among avian influenza viruses of the N4, N5, N6, and N8 neuraminidase subtypes","volume":"92","author":"Choi","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2022.07.001_bib17","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/651605","article-title":"Rapid selection of oseltamivirand peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts","volume":"50","author":"Memoli","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.apsb.2022.07.001_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A (H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.apsb.2022.07.001_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.apsb.2022.07.001_bib20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0891-5849(01)00724-9","article-title":"Reactive oxygen species, antioxidants, and the mammalian thioredoxin system","volume":"31","author":"Nordberg","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2022.07.001_bib21","first-page":"1","article-title":"Redox control in the pathophysiology of influenza virus infection","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Microbial"},{"key":"10.1016\/j.apsb.2022.07.001_bib22","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1096\/fj.09-135590","article-title":"Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species","volume":"23","author":"Lazrak","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2022.07.001_bib23","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/15548627.2019.1580089","article-title":"Influenza M2 protein regulates MAVS-mediated signaling pathway through interacting with MAVS and increasing ROS production","volume":"15","author":"Wang","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2022.07.001_bib24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/ars.2010.3512","article-title":"Redox regulation of the influenza hemagglutinin maturation process: a new cell-mediated strategy for anti-influenza therapy","volume":"15","author":"Sgarbanti","year":"2011","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.apsb.2022.07.001_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.micinf.2017.08.008","article-title":"The role of oxidative\u00a0stress in influenza virus infection","volume":"19","author":"Liu","year":"2017","journal-title":"Microb Infect"},{"key":"10.1016\/j.apsb.2022.07.001_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mehy.2009.04.052","article-title":"Practical strategies for\u00a0targeting NF-\u03baB and NADPH oxidase may improve survival during lethal influenza epidemics","volume":"74","author":"McCarty","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.apsb.2022.07.001_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s11658-020-00211-2","article-title":"Metabolic host response and therapeutic approaches to influenza infection","volume":"25","author":"Keshavarz","year":"2020","journal-title":"Cell Mol Biol Lett"},{"key":"10.1016\/j.apsb.2022.07.001_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3390\/v10080392","article-title":"Redox biology of respiratory viral infections","volume":"10","author":"Khomich","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib29","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1515\/BC.2008.148","article-title":"Influenza viruses and the NF-\u03baB signaling pathway\u2014towards a novel concept of antiviral therapy","volume":"389","author":"Ludwig","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.apsb.2022.07.001_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/ars.2005.7.395","article-title":"Redox regulation of\u00a0NF-\u03baB activation: distinct redox regulation between the cytoplasm\u00a0and the nucleus","volume":"7","author":"Kabe","year":"2005","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.apsb.2022.07.001_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/vim.2019.0032","article-title":"Role of the innate cytokine storm induced by the influenza A virus","volume":"32","author":"Gu","year":"2019","journal-title":"Viral Immunol"},{"key":"10.1016\/j.apsb.2022.07.001_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/08923973.2018.1440591","article-title":"In\u00a0vitro immunomodulatory activity of celastrol against influenza A virus infection","volume":"40","author":"Khalili","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.apsb.2022.07.001_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003845","article-title":"Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infection","volume":"10","author":"Wei","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2022.07.001_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbapap.2011.07.001","article-title":"Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure","volume":"1824","author":"Kido","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2022.07.001_bib35","first-page":"1372","article-title":"Influenza Virus Down-Modulates G6PD expression and activity to induce oxidative stress and promote its replication","volume":"6","author":"De Angelis","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2022.07.001_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2240","article-title":"Reactive oxygen species as potential antiviral targets","volume":"32","author":"Sander","year":"2022","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.apsb.2022.07.001_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.tips.2011.09.001","article-title":"Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy","volume":"33","author":"Vlahos","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2022.07.001_bib38","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.2174\/138161211798357728","article-title":"Intracellular redox signaling as therapeutic target for novel antiviral strategy","volume":"17","author":"Nencioni","year":"2011","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.apsb.2022.07.001_bib39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.apsb.2022.07.001_bib40","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphar.2020.561334","article-title":"Anti-SARS-CoV natural products with the potential to inhibit SARS-CoV-2 (COVID-19)","volume":"11","author":"Verma","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2022.07.001_bib41","first-page":"3194","article-title":"Natural products may interfere with SARS-CoV-2 attachment to the host cell","volume":"39","author":"Elfiky","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.apsb.2022.07.001_bib42","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/med.21707","article-title":"Development of anti-influenza agents from natural products","volume":"40","author":"Zhang","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2022.07.001_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1039\/C1NP00053E","article-title":"Influenza neuraminidase: a druggable target for natural products","volume":"29","author":"Grienke","year":"2012","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.apsb.2022.07.001_bib44","article-title":"Antiviral activity of ethanol extract of Geranii Herba and its components against influenza viruses via neuraminidase inhibition","volume":"9","author":"Choi","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2022.07.001_bib45","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.3390\/molecules25194387","article-title":"Protective effect of flavonoids from Ohwia caudata against influenza a virus infection","volume":"25","author":"Kwon","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2022.07.001_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8824934","article-title":"Anti-influenza activity of an ethyl acetate fraction of a Rhus verniciflua ethanol extract by neuraminidase inhibition","author":"Kim","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2022.07.001_bib47","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1142\/S0192415X19500678","article-title":"Aloe vera and its components inhibit influenza A virus-induced autophagy and replication","volume":"47","author":"Choi","year":"2019","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.apsb.2022.07.001_bib48","first-page":"13829","article-title":"Phytochemical compounds and pharmacological activities of Vitis vinifera L","volume":"11","author":"Insanu","year":"2021","journal-title":"Appl Chem"},{"key":"10.1016\/j.apsb.2022.07.001_bib49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3390\/v13071263","article-title":"Antiviral activity of Vitis vinifera leaf extract against SARS-CoV-2 and HSV-1","volume":"13","author":"Zannella","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib50","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/978-3-319-67045-4_12","article-title":"Natural products and hepatitis C virus","volume":"19","author":"S\u00e9ron","year":"2018","journal-title":"Nat Antimicrob Agents"},{"key":"10.1016\/j.apsb.2022.07.001_bib51","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.4110\/in.2020.20.e32","article-title":"Morin hydrate inhibits influenza virus entry into host cells and has anti-inflammatory effect in influenza-infected mice","volume":"20","author":"Hong","year":"2020","journal-title":"Immune Network"},{"key":"10.1016\/j.apsb.2022.07.001_bib52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","article-title":"Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity","volume":"119","author":"Kim","year":"1997","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.apsb.2022.07.001_bib53","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0969-2126(98)00075-6","article-title":"Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase","volume":"6","author":"Varghese","year":"1998","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2022.07.001_bib54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/jm9703754","article-title":"Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B","volume":"41","author":"Taylor","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2022.07.001_bib55","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1016\/S0960-894X(96)00542-2","article-title":"Novel inhibitors of influenza sialidases related to GG167 structure\u2013activity, crystallographic and molecular dynamics studies with 4H-pyran-2-carboxylic acid 6-carboxamides","volume":"6","author":"Smith","year":"1996","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2022.07.001_bib56","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.2174\/138161212803530763","article-title":"NF-\u03baB as a target for modulating inflammatory responses","volume":"18","author":"Gasparini","year":"2012","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.apsb.2022.07.001_bib57","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1128\/JVI.00909-08","article-title":"NF-\u03baB signaling differentially regulates influenza virus RNA synthesis","volume":"82","author":"Kumar","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.apsb.2022.07.001_bib58","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.881801","article-title":"Influenza virus and cell signaling pathways","volume":"17","author":"Gaur","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.apsb.2022.07.001_bib59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mito.2021.03.008","article-title":"Endoplasmic reticulum & mitochondrial calcium homeostasis: the interplay with viruses","volume":"58","author":"Panda","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.apsb.2022.07.001_bib60","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s00018-014-1615-2","article-title":"Antiviral strategies against influenza virus: towards new therapeutic approaches","volume":"71","author":"Loregian","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2022.07.001_bib61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/rmv.352","article-title":"Functional balance between haemagglutinin and neuraminidase in influenza virus infections","volume":"12","author":"Wagner","year":"2002","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.apsb.2022.07.001_bib62","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.3390\/molecules16032032","article-title":"Antioxidant therapy as a potential approach to severe influenza-associated complications","volume":"16","author":"Uchide","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2022.07.001_bib63","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bcp.2009.08.025","article-title":"N-Acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus","volume":"79","author":"Geiler","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2022.07.001_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2014.06.013","article-title":"N-Acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury","volume":"22","author":"Zhang","year":"2014","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.apsb.2022.07.001_bib65","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/irv.12171","article-title":"Adjunctive therapies and immunomodulating agents for severe influenza","volume":"7","author":"Hui","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.apsb.2022.07.001_bib66","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/mds.28084","article-title":"SARS-CoV-2: at the crossroad between aging and neurodegeneration","volume":"35","author":"Lippi","year":"2020","journal-title":"Mov Disord"},{"key":"10.1016\/j.apsb.2022.07.001_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","article-title":"Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection","volume":"51","author":"Delgado-Roche","year":"2020","journal-title":"Arch Med Res"},{"key":"10.1016\/j.apsb.2022.07.001_bib68","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.toxrep.2020.06.003","article-title":"Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention","volume":"7","author":"Nasi","year":"2020","journal-title":"Toxicol Rep"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522003124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383522003124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T23:25:27Z","timestamp":1748474727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383522003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2211383522003124"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2022.07.001","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitisin B inhibits influenza A virus replication by multi-targeting neuraminidase and virus-induced oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2022.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}